Search
Selected Filter
Displaying 11–20 of 507 news results
-
Neurotech’s Encapsulated Cell Technology Receives FDA Approval for Treatment of MacTel
Research NewsThe technology was previously funded by the Foundation for the treatment of retinitis pigmentosa and dry age-related macular degeneration.
-
Foundation News
With nearly two decades of leadership in vision and neuroscience research and a committed tenure with the Foundation, Dr. Laster will spearhead the Foundation’s scientific strategy in her new role.
-
Adverum Advancing Wet AMD Gene Therapy into Phase 3 Clinical Trials
Research NewsIn earlier clinical trials, the emerging gene therapy greatly reduced the treatment burden associated with injections of approved anti-VEGF therapies.
-
LCA4 Gene Therapy Restores Meaningful Vision for Blind Children
Research NewsMeiraGTx hopes to apply for marketing approval in the UK for the gene therapy.
-
Foundation Fighting Blindness Urges Prioritization of Vision Research
Foundation NewsA Message from Jason Menzo, CEO, Foundation Fighting Blindness
-
RD Fund Invests in Perceive Pharma for Development of Neuroprotective Therapies
Research NewsPerceive Pharma is a spin out of Perceive Biotherapeutics.
-
Foundation Fighting Blindness Celebrates 20 Years of VisionWalk
Foundation NewsVisionWalk has been uniting communities across the country for 20 years, all while raising awareness and funding research driving treatments and cures for blinding diseases.
-
Harriet Finkelstein, Foundation Angel, Passes Away
Foundation NewsThough unaffected by vision loss, she brought great passion to driving the Foundation’s mission.
-
Foundation News
The free, online event at 7 p.m. ET on March 13, 2025, will feature presentations from Christine Kay, MD, Vitreoretinal Associates in Gainesville, Florida, and Thomas Mendel, MD, PhD, Ohio State University Wexner Medical Center.
-
Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy
Research NewsThe Foundation is a founding investor in Atsena.
